Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding

New England Journal of Medicine

Volumn 343, Issue 12, 2000, Pages 834-839

  Lanas, Angel ^a   Bajador, Eduardo ^b   Serrano, Pedro ^a   Fuentes, Javier ^b   Carreño, Sofía ^a   Guardia, Jesusa ^c   Sanz, Mercedes ^c   Montoro, Miguel ^d   Sáinz, Ricardo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

^d HOSPITAL SAN PEDRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STOMACH PROTECTION; THROMBOCYTE AGGREGATION INHIBITION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ESOPHAGITIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; ODDS RATIO; PEPTIC ULCER HEMORRHAGE; RISK FACTORS; VASODILATOR AGENTS;

EID: 0034699601     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200009213431202     Document Type: Article

References (24)

1. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease
2. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
3. Prophylactic aspirin and risk of peptic ulcer bleeding
4. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
5. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding
6. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat
7. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
8. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process
9. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers
10. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa
11. Transdermal nitroglycerin prevents nonsteroidal anti-inflammatory drug gastropathy
12. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats
13. Aspirin-related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use
14. Nitric oxide-mediated cyclooxygenase activation: A key event in the antiplatelet effects of nitrovasodilators
15. Effects of nitrate and prophylactic aspirin on upper gastrointestinal bleeding: A retrospective case-control study
16. In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016
17. Nitric oxide donating flurbiprofen (HCT 1026) causes less endoscopic damage in healthy volunteers than flurbiprofen
18. Endoscopic comparison of three aspirin preparations and placebo
19. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
20. Mechanisms of mucosal injury and healing: The role of nonsteroidal anti-inflammatory drugs
21. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: A prospective observational cohort study
22. Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed
23. Evidence of aspirin use in both upper and lower gastrointestinal perforation
24. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons